UTSW Researchers Develop Tool to Predict Breast Cancer Immunotherapy Response
UT Southwestern Medical Center researchers developed a tool to predict breast cancer patients' response to immunotherapies by analyzing gene expression in cell mixtures from biopsies, reported in Cell Reports Medicine. Assistant Professor Isaac Chan emphasized understanding tumor cellular composition for improving immunotherapy efficacy, highlighting the role of natural killer (NK) cells in fighting cancer. Identifying reprogrammed NK cells in breast tumors suggests therapeutic targeting potential, offering insights for improving patient outcomes.